WO2002004624A9 - Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci - Google Patents

Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci

Info

Publication number: WO2002004624A9
Authority: WO; WIPO (PCT)
Prior art keywords: protein; ligand; screening; dna; novel
Prior art date: 2000-07-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

PCT/JP2001/005877

Other languages

English (en)

French (fr)

Other versions

WO2002004624A1 (fr

Inventor

Takeo Moriya

Takashi Ito

Yasushi Shintani

Nobuyuki Miyajima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-07

Filing date

2001-07-06

Publication date

2002-03-28

2001-07-06 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2001-07-06 Priority to AU2001271025A priority Critical patent/AU2001271025A1/en

2001-07-06 Priority to US10/332,155 priority patent/US20040038238A1/en

2002-01-17 Publication of WO2002004624A1 publication Critical patent/WO2002004624A1/ja

2002-03-28 Publication of WO2002004624A9 publication Critical patent/WO2002004624A9/ja

2003-01-07 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PCT/JP2001/005877 2000-07-07 2001-07-06 Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci Ceased WO2002004624A1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
AU2001271025A AU2001271025A1 (en)	2000-07-07	2001-07-06	Novel g protein-coupled receptor protein and dna thereof
US10/332,155 US20040038238A1 (en)	2000-07-07	2001-07-06	Novel g protein-coupled receptor protein and dna thereof

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2000-211988		2000-07-07
JP2000211988		2000-07-07
JP2000-395596		2000-12-26
JP2000395596		2000-12-26

Publications (2)

Publication Number	Publication Date
WO2002004624A1 WO2002004624A1 (fr)	2002-01-17
WO2002004624A9 true WO2002004624A9 (fr)	2002-03-28

Family

ID=26595917

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/JP2001/005877 Ceased WO2002004624A1 (fr)	2000-07-07	2001-07-06	Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci

Country Status (3)

Country	Link
US (1)	US20040038238A1 (ja)
AU (1)	AU2001271025A1 (ja)
WO (1)	WO2002004624A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2004054617A1 (ja) *	2002-12-13	2006-04-20	協和醗酵工業株式会社	中枢疾患の予防および／または治療剤
WO2010091692A2 (en) *	2009-04-30	2010-08-19	H. Lundbeck A/S	Constitutively active mutants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1007563A4 (en) *	1997-06-12	2003-04-16	Smithkline Beecham Corp	HM74A RECEPTOR
EP1190052A1 (en) *	1999-07-02	2002-03-27	Millennium Pharmaceuticals, Inc.	16405 receptor, a g-protein coupled receptor

2001
- 2001-07-06 WO PCT/JP2001/005877 patent/WO2002004624A1/ja not_active Ceased
- 2001-07-06 US US10/332,155 patent/US20040038238A1/en not_active Abandoned
- 2001-07-06 AU AU2001271025A patent/AU2001271025A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20040038238A1 (en)	2004-02-26
AU2001271025A1 (en)	2002-01-21
WO2002004624A1 (fr)	2002-01-17

Publication	Publication Date	Title
WO2002084286A1 (en)	2002-10-24	Screening method
EP1432433A4 (en)	2006-08-30	ANTAGONISTS
WO2001077172A3 (en)	2003-01-30	Non-endogenous, constitutively activated known g protein-coupled receptors
EP2526968A3 (en)	2013-05-22	Nogo receptor antagonists
WO2004082623A3 (en)	2005-01-13	Substituted piperidine compounds
WO2001096565A3 (en)	2002-08-01	Binding agents: chimeric ligand/receptor proteins
WO2006131659A3 (fr)	2007-02-01	Compositions de liant rapide pour pieces et ouvrages en beton contenant un sel de calcium
WO2002070655A3 (en)	2003-10-16	Mouse cytokine receptor
WO2002044368A1 (fr)	2002-06-06	Nouvelles proteines du recepteur couple a la proteine g et leurs adn
CA2323363A1 (en)	1999-09-16	Novel compositions of eprosartan
WO2002102839A3 (en)	2003-07-24	Novel g-protein coupled receptors and dna sequences thereof
WO2001059117A3 (en)	2002-01-03	Seven-transmembrane proteins/g-protein coupled receptors
WO2003018798A3 (en)	2003-12-04	G-protein coupled receptor and dna sequences thereof
WO2004094400A3 (en)	2005-02-24	Substituted benzopyrans as selective estrogen receptor-beta agonists
WO2004096196A3 (en)	2005-03-10	Treatment of incontinence with 5htc2 agonists
WO2002004624A9 (fr)	2002-03-28	Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci
WO2007000672A3 (en)	2007-04-12	Peptidic antagonists of class iii semaphorins/neuropilins complexes
BR0014090A (pt)	2002-05-21	Método para rastreamento de ligandos de ligação à subunidade alfa2delta-1
WO2001049847A3 (en)	2002-05-30	26904, 38911, and 39404, seven-transmembrane proteins/g-protein coupled receptors
WO2002060948A1 (fr)	2002-08-08	Nouvelle proteine recepteur couplee a une proteine g et adn correspondant
WO2003012104A1 (en)	2003-02-13	Novel g protein-coupled receptor protein and dna thereof
WO2003059881A3 (en)	2003-11-27	Dna minor groove binding compounds
AU2003242106A1 (en)	2003-12-22	Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
WO2002061075A1 (fr)	2002-08-08	Proteine de recepteur couple aux proteines g et adn correspondant
IL150824A0 (en)	2003-02-12	Screening method

Legal Events

Date	Code	Title	Description
2002-01-17	AK	Designated states	Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW
2002-01-17	AL	Designated countries for regional patents	Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG
2002-02-14	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
2002-03-13	121	Ep: the epo has been informed by wipo that ep was designated in this application
2002-03-28	AK	Designated states	Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW
2002-03-28	AL	Designated countries for regional patents	Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG
2002-03-28	COP	Corrected version of pamphlet	Free format text: PAGE 34, DESCRIPTION, REPLACED BY CORRECT PAGE 34
2003-01-06	WWE	Wipo information: entry into national phase	Ref document number: 10332155 Country of ref document: US
2003-05-22	REG	Reference to national code	Ref country code: DE Ref legal event code: 8642
2003-08-20	122	Ep: pct application non-entry in european phase
2004-02-17	NENP	Non-entry into the national phase	Ref country code: JP